Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
1
10%
Ph early_phase_1
1
10%
Ph phase_3
6
60%
Ph phase_4
2
20%

Phase Distribution

1

Early Stage

0

Mid Stage

8

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 3Large-scale testing
6(60.0%)
Phase 4Post-market surveillance
2(20.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(7)
Terminated(1)
Other(2)

Detailed Status

Completed7
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (10.0%)
Phase 36 (60.0%)
Phase 42 (20.0%)
N/A1 (10.0%)

Trials by Status

completed770%
terminated110%
unknown220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10